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A genome-wide survey of human short-term memory
Abstract
Recent advances in the development of high-throughput genotyping platforms allow for the unbiased
identification of genes and genomic sequences related to heritable traits. In this study, we analyzed
human short-term memory, which refers to the ability to remember information over a brief period of
time and which has been found disturbed in many neuropsychiatric conditions, including schizophrenia
and depression. We performed a genome-wide survey at 909 622 polymorphic loci and report six
genetic variations significantly associated with human short-term memory performance after
genome-wide correction for multiple comparisons. A polymorphism within SCN1A (encoding the alpha
subunit of the type I voltage-gated sodium channel) was replicated in three independent populations of
1699 individuals. Functional magnetic resonance imaging during an n-back working memory task
detected SCN1A allele-dependent activation differences in brain regions typically involved in working
memory processes. These results suggest an important role for SCN1A in human short-term memory.
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Recent advances in the development of high-throughput genotyping platforms allow for the
unbiased identification of genes and genomic sequences related to heritable traits. In this
study, we analyzed human short-term memory, which refers to the ability to remember
information over a brief period of time and which has been found disturbed in many
neuropsychiatric conditions, including schizophrenia and depression. We performed a
genome-wide survey at 909 622 polymorphic loci and report six genetic variations significantly
associated with human short-term memory performance after genome-wide correction for
multiple comparisons. A polymorphism within SCN1A (encoding the a subunit of the type I
voltage-gated sodium channel) was replicated in three independent populations of 1699
individuals. Functional magnetic resonance imaging during an n-back working memory task
detected SCN1A allele-dependent activation differences in brain regions typically involved in
working memory processes. These results suggest an important role for SCN1A in human
short-term memory.
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Introduction
The search for molecules related to cognitive traits
such as human memory functions is key for the
understanding of the underlying biology and for the
identification of molecular pathways possibly amen-
able to pharmacologic intervention in pathological
conditions. Unlike candidate-gene association stu-
dies, which depend on pre-existing information,1–4
recent advances in the development of high-density
genotyping platforms now allow for high-resolution
genome-wide association studies (GWAS) of poly-
genic phenotypes resulting in the identification
of novel genes and genomic sequences related to
cognitive traits.5
In this study, we used an individual genome-wide
screen with more than 900000 single-nucleotide
polymorphisms (SNPs) in 333 Swiss healthy young
individuals to identify genetic loci related to human
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short-term memory processes as assessed by a verbal
immediate recall task. SNPs reaching statistically
significant levels after genome-wide correction for
multiple comparisons were analyzed in a second
cohort of 254 Swiss healthy young individuals who
performed an identical immediate recall task (phase
2). Significant phase 2 SNPs were further analyzed in
922 elderly, non-demented individuals from Germany
(phase 3) and in 523 healthy young individuals from
Serbia (phase 4) who had also performed verbal
immediate recall tasks. To further validate and
characterize the findings of the behavioral genetics
studies, we used functional magnetic resonance
imaging (fMRI), which can detect genotype-depen-
dent differences in brain activations during cognitive
tasks.2,3,6
Materials and methods
Memory testing
Swiss sample (phases 1 and 2). We recruited 333
(phase 1) and 254 (phase 2) healthy, young Swiss
university students or age-matched employees/
trainees. Of the 587 participants of phases 1 and 2,
426 were women and 161 were men. Age was
22.1±3.2 years (mean±s.d.). After complete
description of the study to the participants, written
informed consent was obtained. The ethics committee
of the Canton of Zurich, Switzerland approved the
study protocol. Participants viewed six series of five
semantically unrelated nouns presented at a rate of
one word per second with the instruction to learn
the words for immediate free recall after each series.
The number of correctly recalled words (hits) was the
relevant output. All participants were tested with a
standardized mental health questionnaire for current
and life-time major psychiatric diseases, smoking and
the use of any medication. In addition, participants
provided information on possible familiar aggregation
of major psychiatric diseases, female participants
gave also information on the use of oral contra-
ceptives and the actual menstrual cycle. Blood was
drawn by using 29ml ethylene-diaminetetraacetic
acid tubes (Sarstedt, Germany), DNA isolation was
carried out according to standard protocols (Qiagen,
Hilden, Germany).
German sample (phase 3). Participants were drawn
from a large population-based cohort of elderly
individuals participating in the AgeCoDe study.
This study follows 3327 non-demented, non-
institutionalized participants aged 75–90 years
recruited through general practitioners in six
German cities. The design of the AgeCoDe study is
given in more detail elsewhere.7,8 The ethics
committees of the participating centers approved the
study. Written informed consent was obtained
from all participants. From the full sample with
available DNA we excluded all participants where
health conditions, medication or other factors
could significantly affect cognitive performance. The
exclusion criteria were: visual or auditory impair-
ments possibly limiting the cognitive evaluation,
neurological disorders (for example, Parkinson
Disease, seizures, transitory ischemic attacks,
stroke, closed head injury with more than 30min
unconsciousness), diabetes, current depression (Geri-
atric Depression scale X6) or intake of tricyclic
antidepressants, poor motivation during testing, first
language other than German, harmful use of alcohol
or alcohol addiction, or medication with benzo-
diazepines. We included 922 participants in this
study.
Neuropsychological testing. All participants were
assessed at their home by trained research assistants
with a battery of tests. These include a structured
interview for the assessment of dementia, the word
list learning task (episodic memory) and the category
fluency task of the consortium to establish a registry
for Alzheimer’s disease battery.9 The total number
of words recalled after the first learning trial
(maximum=10) was used as a measure of verbal
short-term memory.
Serbian sample (phase 4). Study participants were
523 healthy young individuals (351 female and 172
male students of the School of Medicine of the
University of Belgrade, age 20.3±0.9 years) who
agreed to participate in a study of the genetic basis
of human cognition. Free recall of a short story
narrative (immediate and 30min delayed recall of
items from Story A of the Logical Memory test;
Wechsler Memory Scale-revised)10 was used to
assess verbal memory performance. Participants
completed also a questionnaire related to general
health, living circumstances, parental education and
subjective learning capacity.
Statistics and single-nucleotide polymorphism
selection
The GWAS (phase 1) and the phase 2 replication
studies were run under the assumption of an additive
model (trend test). False discovery rate (FDR) was
used to correct for genome-wide multiple testing in
phase 1. The FDR-corrected significance level (P1_FDR)
was set to 0.05. After initial quality control (QC), we
used following criteria to identify significant phase 1
SNPs to follow in phase 2: (a) P1_FDRp0.05; (b) minor
allele frequency X0.05; (c) Hardy–Weinberg equili-
brium PX0.05; (d) intragenic SNP localization (that
is, within genes/open-reading frames or within a
haplotype block extending to an adjacent gene/open-
reading frame). Of the 650 SNPs fulfilling criterion (a)
only six SNPs fulfilled the additional criteria (b)
through (d). Genomic control analysis using all SNP
data was used to calculate the inflation factor l,
which was 1.0 in the homogenous Swiss sample from
phase 1. Thus, the significances reported herein are
not affected by stratification.
The haplotype trend regression method was used for
haplotype analysis. Maximum expectation maximization
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iterations and expectation maximization convergence
tolerance were set to 50 and 0.0001, respectively.
Minimum haplotype frequency was set to 5%. The
computed significance applied to the full model, that
is, haplotypesþnon-haplotype covariates.
In the German sample of elderly individuals,
analysis of variance was used to calculate the
significance of association between SNPs and mem-
ory performance. Each analysis was corrected for age,
gender, the presence of mild cognitive impairment,
and education. In the Serbian sample of young
students, analysis of variance corrected for gender
and living circumstances effects was used to calcu-
late the significance of association between SNP
rs10930201 and memory performance.
Helix Tree (version 6.4.1, Golden Helix Inc.,
Bozeman, MT, USA) and SPSS 11 (SPSS Inc.,
Chicago, IL, USA) were used for statistical analyses.
Array-based single-nucleotide polymorphism
genotyping
Samples were processed as described in the Genome-
Wide Human SNP Nsp/Sty 6.0 User Guide
(Affymetrix Inc., Santa Clara, CA, USA). Briefly,
genomic DNA concentration was determined by using
a Nano-Drop ND-1000 and adjusted to 50ng ml–1 in
water. In all, 250ng of DNA was digested in parallel
with 10 units of Sty I and Nsp I restriction enzymes
(New England Biolabs, Beverly, MA, USA) for 2h at
37 1C. Enzyme-specific adapter oligonucleotides were
then ligated onto the digested ends with T4 DNA
Ligase for 3h at 16 1C. After adjustment to 100ml with
water, 10ml of the diluted ligation reactions were
subjected to PCR. Three PCR reactions of 100ml were
performed for Sty-digested products and four PCR
reactions for Nsp. PCR was performed using Titanium
Taq DNA Polymerase (Clontech, Mountain View, CA,
USA) in the presence of 4.5mM PCR primer 002
(Affymetrix), 350mM each dNTP (Clontech), 1M G-C
Melt (Clontech) and 1 Titanium Taq PCR Buffer
(Clontech). Cycling parameters were as follows, initial
denaturation at 94 1C for 3min, amplification at 94 1C
for 30 s, 60 1C for 45 s and extension at 68 1C for 15 s
repeated a total of 30 times, final extension at 68 1C for
7min. Reactions were then verified to migrate at an
average size between 200 and 1100bp using 2% TBE
gel electrophoresis. PCR products were combined and
purified with the Filter Bottom Plate (Seahorse
Bioscience, North Billerica, MA, USA) using Agen-
court Magnetic Beads (Beckman Coulter, Fullerton,
CA, USA). Purified PCR products were quantified on
a Zenith 200rt microplate reader (Anthos-Labtec,
Cambridge, UK). In all, 4–5mgml–1 were obtained on
average for each sample. From this stage on, the SNP
Nsp/Sty 5.0/6.0 Assay Kit (Affymetrix) was used.
Around 250mg of purified PCR products were frag-
mented using 0.5 units of DNAse I at 37 1C for 35min.
Fragmentation of the products to an average size
< 180 bp was verified using 4% TBE gel electrophor-
esis. After fragmentation, the DNA was end labeled
with 105 units of terminal deoxynucleotidyl transfer-
ase at 37 1C for 4h. The labeled DNA was then
hybridized onto Genome-Wide Human SNP 6.0 Array
at 50 1C for 18h at 60 revolutions per minute. The
hybridized array was washed, stained, and scanned
according to the manufacturer’s (Affymetrix) instruc-
tions using Affymetrix GeneChip Command Console
(AGCC, version 0.0.0.676). Generation of SNP calls
and array quality control were performed using
the Affymetrix Genotyping Console Software 3.0
(Affymetrix Inc.). According to the manufacturer’s
recommendation, Contrast QC was chosen as
QC metric, using the default value ofX0.4. Individual
QC Call Rate Threshold was set to default of X0.86.
Mean Call Rate for all samples averaged 98.7%.
All samples passing QC criteria were subsequently
genotyped using the Birdseed (v1) algorithm. A total
of 909 622 SNPs were genotyped and imported
into Helix Tree (version 6.4.1). For association
testing 67 929 markers with fewer than two alleles
and 30 markers with insufficient cardinality were
skipped leaving a total of 841 663 markers to be
analyzed.
Singleplex single-nucleotide polymorphism genotyping
Singleplex genotyping was carried out with
Pyrosequencing on a PyroMarkID System (Biotage,
Uppsala, Sweden). The chip-based SNP_A-8386800
(rs10930201) was also genotyped by Pyrosequencing
in the samples from phase 1 and phase 2. In the phase
1 sample, the level of convergence between chip- and
Pyrosequencing-based genotype calls was 100%. The
non-synonymous SNP rs2298771 was also genotyped
by Pyrosequencing. Please contact the authors for the
detailed list of singleplex primers.
Magnetic resonance imaging
Participants. In total, 9 men and 15 women; median
age 22 years, range 18–25 years.
Working memory functional magnetic resonance
imaging experiment. There was a single fMRI time-
series with a two-back task assessing working memory
and a baseline task (‘x-target’ task) measuring concentra-
tion. The two-back task required participants to
respond to a letter repeat with one intervening letter
(for example, Sfsgy). The ‘x-target’ task required
participants to respond to the occurrence of the letter
‘x’ in a sequence of letters (for example, NlXgy).
We presented 50 upper- or lowercase letters typed
in black on white background. The use of upper-
and lowercase letters prevented a visual-matching
strategy. There were five blocks of 26 s per condition.
Each block comprised 13 upper- or lowercase letters,
which were presented for 2 s each.
Data acquisition. Magnetic resonance measurements
were performed using a 3 T Philips Intera whole-body
magnetic resonance scanner equipped with an
eight-channel Philips (Best, The Netherlands) SENSE
head coil. Functional data were obtained from 32
transverse slices parallel to the anterior commissure-
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posterior commissure plane covering the whole
brain with a measured spatial resolution of
2.8 2.8 4mm3 (acquisition matrix 8080) and a
reconstructed resolution of 1.71.74mm3. Data
were acquired with a SENSE-sshEPI sequence with an
acceleration factor of R=2.0.11 Other scan parameters
were echo time (TE) = 35ms, repetition time (TR) =
3000ms, y=821. A 3D T1-weighted anatomical scan
was obtained for the voxel-based morphometry
analysis with a measured spatial resolution of
1 1 1.5mm3 (acquisition matrix 224224) and a
reconstructed resolution of 0.90.9 0.8mm3,
TE=2.3ms, TR=20ms, y=201, no interslice gaps.
Analysis of functional magnetic resonance imaging
data. Image pre- and postprocessing and the
statistical analyses were performed using SPM2.
Standard preprocessing procedures were applied,
realignment, normalization and spatial smoothing
(8mm). On the single subject level, data were
analyzed according to the fixed effects model
(SPM2; http://www.fil.ion.ucl.ac.uk/spm/). Contrasts
were computed for each subject comparing the two-
back task to the x-target task. At the second level,
within-subject contrasts were entered into random
effects analyses (Two sample t-tests, SPM2)12 and
correlated with behavioral performance (simple
regression, SPM2). The six head movement
parameters were included in the model as confound-
ing factors. Data were high-pass filtered with a filter-
value tailored to each fMRI time-series according to
2 stimulus onset asynchronyTR. Threshold was
set at a P<0.001 level, uncorrected for multiple
comparisons, with an extent threshold of 20 voxels.
SPM2 coordinates refer to standard brains from the
Montreal Neurological Institute.
Analysis of anatomical magnetic resonance imaging
data. Image preprocessing was carried out with
Statistical Parametric Mapping (SPM2) software
(http://www.fil.ion.ucl.ac.uk/spm) using optimized
voxel-based morphometry13,14 implemented in
scripts written by C Gaser (http://dbm.neuro.uni-jena.
de/vbm/) that computes voxel-wise compari-
sons of gray matter, white matter and liquor
probabilities between groups. We normalized and
segmented the native magnetic resonance images
using the MNI 152 a priori maps. In additional, we
modulated the gray matter images with the Jacobian
determinant that account for volumetric changes
introduced by the spatial normalization. These gray
matter images were then smoothed with a 12mm
Gaussian kernel and subjected into a voxel-wise
statistical analysis.
Data analysis of cortical gene expression data
Data are based on the survey of genetic
human cortical gene expression published recently
by Myers et al.15 Gene expression studies of 178
samples from the cerebral cortex of neurpathologi-
cally normal brains were carried out with the
Illunima HumanRefseq-8 Expression BeadChip (Illu-
mina Inc., San Diego, CA, USA). For genome-wide
genotyping, the Affymetrix GeneChip Human Map-
ping 500K Array Set was used. The complete data
files were downloaded from http://labs.med.miami.
edu/myers/. SCN1A transcript probe was GI_29893558
(NM_006920.2) and expression levels of GI_29893558
were used as dependent variable. The genetic asso-
ciation analysis was run under the assumption of an
additive model (trend test), which was also used tor
the GWAS on memory performance.
Results
Genome-wide survey and replication studies
Participants (phase 1) viewed six series of five
semantically unrelated nouns presented at a rate of
one word per second with the instruction to learn the
words for immediate free recall after each series,
resulting in a recall of totally 24.0±0.2 (mean±
s.e.m.) words. Individual genotyping with the Affy-
metrix Genome-Wide Human SNP Array 6.0 showed
that six common SNPs were significantly associated
with immediate recall performance also after genome-
wide correction (FDR) for multiple comparisons
(Figure 1) (see Materials and Methods section). The
significant SNPs from phase 1 (n=6) were genotyped
in a second cohort of 254 healthy individuals who
performed the identical immediate recall task. In this
group, mean immediate recall was 23.5±0.2 words.
SNP rs10930201, located within the gene encoding
voltage-gated sodium channel type 1a (SCN1A), was
significantly associated with immediate recall also in
the phase 2 sample (Figure 1 and Supplementary
Figure 1). In both samples, carriers of the minor allele
presented with poorer short-term memory perfor-
mance in an allele dose-dependent manner
(Table 1). This result was also confirmed in the phase
3 sample (P= 0.03), which consisted of 922 non-
demented elderly individuals (mean age: 80 years,
range: 75–90 years) and in the phase 4 sample
(P=0.0002, Table 1), which consisted of 523 healthy
young individuals (mean age: 20 years, range: 19–27
years) (see Materials and Methods section). In the
samples from phases 1, 2 and 4, we observed no
significant association of SNP rs10930201 with
delayed recall of the presented material (phases 1
and 2: 5min and 24h delayed recall; phase 4: 30min
delayed recall; all Ps >0.1). In the phase 3 sample of
elderly individuals, this SNP was associated (in the
same allele-dependent manner) with delayed recall
performance (10min delayed recall, P=0.006). How-
ever, after correction for immediate recall perfor-
mance, the association between rs10930201 and
delayed recall failed to reach significance (P>0.05),
indicating a carry-over genotype effect from the
immediate to the delayed recall test. These findings
suggest that the SCN1A genotype is mainly related to
short-term memory processes as measured by im-
mediate recall tests.
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Analysis of all 39 SCN1A SNPs represented on the
chip showed that nine intragenic SNPs were signifi-
cantly associated with immediate recall performance
in phase 1 (P<0.05, corrected for 39 SNPs, Supple-
mentary Figure 1a). Haplotype analysis showed that a
four SNP haplotype covering almost the entire gene
and harboring the intronic SNP rs10930201 was
significantly associated with memory performance
(P=0.0000002) (Supplementary Figure 1a). In the
phase 2 sample, this haplotype was significantly
associated with memory performance as well
(P=0.004, Supplementary Figure 1b). In the phase 1
sample, SNP rs6731900 located 1 kb 50 to the TTC21B
gene (encoding tetratricopeptide repeat domain 21B)
and 103kb 30 to SCN1A SNP rs10930201 was also
significantly (that is, FDR-corrected) associated
with immediate recall performance (Figure 1).
Although rs6731900 did not replicate in the phase 2
sample (Figure 1), we performed a post hoc analysis
of all informative TTC21B SNPs represented on the
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Figure 1 Genome-wide association and replication. Upper panel: genome-wide results (log10P), corrected for genome-
wide multiple comparisons (false discovery rate (FDR)), are shown in chromosomal order for individually genotyped single-
nucleotide polymorphisms (SNPs) that were tested for association with immediate verbal recall performance in the phase 1
sample of 333 individuals. The red dotted line indicates the FDR-corrected significance level, which was exceeded by six
SNPs. Lower panel: list of significant SNPs (FDR-corrected) with corresponding chromosomal positions and phase 1
significance values. Chromosomal positions were retrieved from the March 2006 UCSC genome browser assembly. MAF,
minor allele frequency; r, genotype-phenotype correlation in phase 1 sample; P, uncorrected significance level in phase 1
sample. The additive model was used for all association tests. The color reproduction of this figure is available on the html
full text version of the manuscript.
Table 1 Genotype-dependent performance in short-term memory tasks in four independent samples from Switzerland,
Germany and Serbia
Genotype
(rs10930201)
Phase 1
(n=333)
Switzerland
Phase 2
(n=254)
Switzerland
Phase 3
(n=922)
Germany
Phase 4
(n=523)
Serbia
n mean±s.e.m. n mean±s.e.m. n mean±s.e.m. n mean±s.e.m.
AA 149 24.8±0.3 120 23.8±0.3 417 4.7±0.2 205 18.2±0.4
AC 144 23.6±0.3 105 23.3±0.3 397 4.5±0.1 251 18.1±0.4
CC 40 22.4±0.5 29 22.5±0.4 108 4.1±0.3 67 15.6±0.6
P=0.00003 P=0.04a P=0.03a P=0.0002a
Abbreviation: GWAS, genome-wide association studies.
aSamples from phases 2, 3 and 4 are replication samples. GWAS was done on the phase 1 sample only.
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6.0 chip (n=10, minor allele frequency >0.05,
Hardy–Weinberg equilibrium P>0.05) to rule out
the possibility that TTC21B rather than SCN1A is
associated with human memory performance. In
the phase 1 sample, we did not observe any FDR-
corrected significant TTC21B SNPs. In addition, no
TTC21B SNPs reaching nominal significance were
observed in the phase 2 sample (Supplementary Table 1).
Genetic variability within SCN1A is linked to human
brain function
Immediate recall performance as assessed in this
study consisted of recalling verbal information im-
mediately after presentation and learning. This kind
of short-term storage is an essential component of
working memory.16,17 To further analyze genotype-
dependent differences in brain activation patterns, we
used a verbal two-back task, which has been widely
used in neuroimaging studies investigating the neural
basis of working memory.18 Participants were re-
quired to monitor a series of visually presented letters
on a trial-by-trial basis. They had to remember the last
two letters in their temporal order, compare the
currently presented letter with the one that occurred
in the two-back task, and update their memory by
dropping the oldest letter and incorporating the most
recently presented letter. We applied the two-back
letter task during fMRI in a sample of 24 healthy
young individuals drawn from the phase 1 sample (12
homozygous carriers of the A allele of SNP
rs10930201, 12 heterozygous AC carriers). The geno-
type groups were matched for sex (five men and seven
women in the homozygous, four men and eight
women in the heterozygous), age and immediate
recall performance (all P-values > 0.8). Performance
was matched to avoid measuring genotype-unrelated
performance effects on brain activations, and to
instead capture genotype-dependent differences in
brain activation patterns. As expected based on the
matching for immediate recall performance on
grounds of data collected in the large sample, there
were no genotype-dependent differences in two-back
task performance in the fMRI (P=0.5). The pooled
data (over both genotype groups) showed robust
activation in a bilateral fronto-parietal network
(Supplementary Figure 2), including Brodmann area
(BA) 6 and 44, as typically found in neuroimaging
studies of working memory17 and as found in our
previous study using the same task and magnetic
resonance scanning protocol.6 During the two-back
task (contrasted with ‘x-target’ baseline task) (see
Materials and Methods section) heterozygous indivi-
duals showed significantly increased brain activa-
tions compared with homozygous A allele carriers in
the right superior frontal gyrus/sulcus, BA 6 (local
maximum at coordinate position (22, 18, 56), t=4.56,
P<0.001; coordinates according to the Montreal
Neurological Institute) (Figure 2a). This area has been
consistently and bilaterally activated by n-back tasks,
independently of stimulus type and identity versus
location monitoring.18,19 In a meta-analysis of working
memory studies,20 this area responded when working
memory needed to be continuously updated and
when temporal order was crucial, which is true for
n-back tasks. Although heterozygous individuals
4
3
2
1
0
4
3
2
1
0
Figure 2 Significant SCN1A allele-dependent differences
in brain activation during a two-back working memory task.
(a) Heterozygous carriers of the minor allele C showed
significantly increased brain activations compared with
homozygous A allele carriers in the right superior frontal
gyrus/sulcus (BA 6). (b) Homozygous A allele carriers
showed significantly increased brain activations compared
with heterozygous individuals in the right inferior frontal
sulcus (BA 44). Activations were overlaid on sagittal,
coronal and horizontal sections of a T1-weighted magnetic
resonance image of SPM2 and showed in color-coded
t-values. Threshold: P<0.001, uncorrected for multiple
comparisons.
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recruited more neural resources in BA 6, homozygous
carriers of the A allele showed increased activity in
the right inferior frontal sulcus, BA 44 (local max-
imum at coordinate position (48, 16, 22), t=4.29,
P<0.001) (Figure 2b). BA 44 is typically activated
during working memory for verbal stimuli,18,20 also
during n-back letter tasks,21–24 and is thought to
contribute to rehearsal or to the active maintenance of
information within working memory.21–24 Whereas most
studies reported left lateralization, several studies also
reported additional activations in the right BA 44,
especially with increasing working memory load (for
example, Braver et al.21; Cohen et al.22).
Studies investigating inter-individual differences in
verbal working memory performance (based on both
genetic and environmental factors) have indicated
that high performers show lower brain activity in
working memory-related brain regions than low
performers.25–27 In the present fMRI experiment,
however, the two genotype groups were performance
matched in terms of verbal short-term memory
capacity based on the data collected in the behavioral
genetics cohort. This matching might have circum-
vented broader genotype-dependent activation
differences within the working-memory network
(for example, in the posterior parietal cortex) but
rather revealed a differential activation pattern in
BA 6 and BA 44.
Automated voxel-based morphometry (SPM2) (see
Materials and Methods section) did not reveal
significant genotype-dependent differences in gray
matter nor white matter concentrations, indicating
that functional imaging results were not biased by
morphological differences.
Discussion
By using an unbiased, genome-wide behavioral
genetics approach combined with functional brain
imaging studies, we present evidence suggesting
that the a subunit of the voltage-gated sodium
channel, type I (protein: Nav1. 1; gene: SCN1A) has
a significant role in human short-term memory.
Specifically, an intronic SCN1A polymorphism was
associated with short-term memory performance in
four independent populations. Furthermore, fMRI
experiments during a two-back working memory
task revealed allele-dependent differences in brain
activations in regions typically involved in working
memory processes.
In the hypothesis-generating sample of 333 partici-
pants, we observed a medium effect size (ES) of the
SCN1A SNP rs10930201 on short-term memory
performance (Cohen’s f=0.24). Recent candidate gene
and genome-wide studies reporting associations of
genetic polymorphisms with specific memory-related
phenotypes observed also medium to large ES with
Cohen’s d-values ranging from 0.4 to 0.8 (for example,
SNPs in BDNF,3 GRM328 and KIBRA5,29). Therefore,
the medium ES observed in this study is within the
range of ES expected in behavioral genetics studies
related to human memory capacity. Assuming a SNP
with a medium ES (Cohen’s d=0.5–0.6), the power of
our initial sample to detect associations at a genome-
wide FDR-corrected alpha error probability ranges
from 67 to 89%. Thus, our initial sample is sufficient
for detecting SNPs with medium to large ES, whereas
it is underpowered for SNPs with small ES. The ES of
the SCN1A SNP rs10930201 on brain activity as
estimated in the fMRI study (Cohen’s d=1.9) was
considerably larger than the corresponding ES in the
behavioral study. Such large ES are characteristic for
imaging genetics studies of brain activity during
memory tasks, as shown for example for several genes
including BDNF (Cohen’s d=2.2)3 and KIBRA
(Cohen’s d=1.6).5 A possible explanation for this
repeatedly reported observation is that biological
phenotypes such as neural activity are more prox-
imate to the direct effects of genetic variability on
gene products and their function, and might therefore
be more sensitive in estimating genotype-dependent
differences in mental processing.30,31 Thus, the size of
the effects of genetic variations on brain activity
seems to be much larger as compared with behavioral
measures. Consequently, in imaging genetics studies
of memory, fewer participants are required to achieve
enough statistical power to detect a significant
genotype effect, than in behavioral genetics studies.
Assuming a SNP with Cohen’s d=2, the power of our
fMRI sample to detect associations at an error
probability equal to 0.001 is 85%. Thus, the fMRI
sample is sufficient for detecting SNPs with ES
typically observed in imaging genetics studies of
brain activity during memory tasks.
It is important to stress that the intronic SCN1A
SNP reported herein is most probably a marker SNP
in linkage disequilibrium with one or more functional
variations located elsewhere within SCN1A. As for
any genetic association study, especially for GWAS on
complex traits, the core message is the identification
of a gene, rather than a specific variation, related to
the phenotype of interest. In our case, additional
issues require a cautious interpretation regarding the
identification of the putative causative variants. First,
SCN1A is essentially covered by one haplotype block,
that is, it is hardly possible to exclude effects of
neighboring and tightly linked SNPs. Second, SCN1A
undergoes considerable alternative splicing,32 thereby
showing the putative functional role of intronic, in
addition to exonic, variants of the voltage-gated
sodium channel Na(v)1.1. Database search (dbSNP)
revealed that SCN1A harbors at least 481 tightly
linked variations located in exonic, intronic and
regulatory regions. One intronic SNP (rs3812718)
located in the splice-donor site of SCN1A exon 5N,
in the vicinity of our intronic SNP (5 kb apart) and in
tight linkage disequilibrium with it (D0 and r2 > 0.9)
was recently shown to have a striking effect on the
percentage of transcripts of the neonatal form of the
SCN1A gene in the adult brain.33 In those individuals
with the common GG genotype, up to 50% of the
transcripts include the neonatal version of exon 5,
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compared with an often undetectable level of the
neonatal version in some participants with the rare
AA genotype.33 Doses of both carbamazepine and
phenytoin, two antiepileptic drugs targeting SCN1A,
are highest in individuals with the AA genotype,34,35
suggesting that the intronic SNP rs3812718 directly
influences the therapeutic dose of antiepileptic
medications and that it is possibly related to the
influence of different SCN1A transcript variants on
electrical signaling.33 To further study the relation of
SCN1A variations on messenger RNA expression
levels, we examined the association between SCN1A
SNPs and cortical expression of the SCN1A transcript
GI_29893558 in the brains of 178 non-demented
deceased individuals (see Materials and Methods
section). The data are based on the recently published
genetic survey of human cortical gene expression.15 A
subset of the SCN1A SNPs reported in our genetic
study of human memory performance are also
represented on the 500 k SNP Array set, which was
used in the study of cortical gene expression. SNP
rs4667869, which is located in the first SCN1A intron
8 kb 50 to marker SNP rs10930201 and which is in
linkage disequilibrium with the SNPs and the
haplotype reported herein, is significantly and addi-
tively associated with messenger RNA expression of
the SCN1A transcript (Supplementary Figure 3). In
addition to these intronic SNPs, SCN1A also harbors a
common non-synonymous SNP (rs2298771), which
results in an amino acid substitution (Thr/Ala) in exon
16. Its functionality, however, is hitherto unknown.
According to the HapMap database (http://hapmap.
ncbi.nlm.nih.gov/), the intronic SNP rs10930201 and
the non-synonymous SNP rs2298771 are in almost
complete linkage disequilibrium (D0 =0.96, r2 = 0.92),
which was also confirmed in the 587 study partici-
pants from phases 1 and 2. Taken together, the SCN1A
locus, which is associated with human memory
performance, harbors multiple tightly linked varia-
tions with documented or putative functionality.
Voltage-gated sodium channels have an important
role in the generation and propagation of the action
potential and consist of an alpha subunit, which forms
the ion conduction pore, and two auxiliary beta
subunits.36 The alpha subunit has four homologous
domains and different genes (SCN1A through
SCN11A) encode different alpha subunits named
Nav1.1 through Nav1.9.37 The SCN1A gene is located
on chromosome 2q24 and contains 27 exons, spanning
B139kb of genomic sequence.38 SCN1A is expressed
in brain regions critical for memory formation,39
regulates excitability of neuronal membranes and
several SCN1Amutations are known to cause a variety
of neurological diseases such as familial hemiplegic
migraine,40 generalized epilepsy with febrile seizures
plus type 241 and severe myoclonic epilepsy of
infancy.42 Some antiepileptic drugs, such as pheny-
toin and carbamazepine, bind to voltage-gated sodium
channels43 and genetic variability within SCN1A may
predict the response to carbamazepine and phenytoin
in patients diagnosed with epilepsy.34,35,44
Interestingly, phenytoin and carbamazepine have
been shown to modulate working memory perfor-
mance in rats. Lamotrigine, another antiepileptic drug
that binds to voltage-gated sodium channels, is an
effective maintenance treatment for bipolar disorder,
particularly for prophylaxis of depression,45 a mental
disorder with commonly observed working memory
deficits.46 A recent fMRI study reports that lamotri-
gine treatment in depressed patients results in
increased activation of brain regions typically in-
volved in working memory processes during an n-
back task,47 as also shown herein.
Taken together, a high-density GWAS followed by
replication studies and an fMRI experiment and
expression data suggest a role for the voltage-gated
sodium channel Na(v)1.1 in human short-term mem-
ory. These results show the usefulness of unbiased
genome-wide approaches and their potential to iden-
tify important molecular pathways related to human
short-term memory. Ultimately, such studies might
promote the development of targeted treatments of
diseases associated with memory disturbances.
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